Figure 1From: Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancerPRC2 gene expression in PC patients. A, comparison of PRC2 mRNA levels in normal prostate, primary and metastatic PC (GEO database). *p < 0.05, **P < 0.01. B, C: prognostic role of EZH2 and SUZ12 mRNA levels in PC sample (Oncomine database).Back to article page